Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

SUPNSUPN
6 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in SUPERNUS PHARMACEUTICALS

GOLDMAN SACHS GROUP INC holds 856,487 shares of SUPN (SUPERNUS PHARMACEUTICALS), worth $44.3M as of 2026-Q1. The position was increased (+29.7% shares). SUPN represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$44.3M

Current Shares

856,487

Total Value Change

+$10.5M

Total Shares Change

-77,465

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
856,487
+29.7%
$44.3M0.0%$54.56
37
2025-Q4
Decreased
660,310
-43.2%
$32.8M0.0%$49.89
0
2025-Q3
Increased
1.2M
+29.8%
$55.6M0.0%$47.60
37
2025-Q2
Increased
896,387
+8.8%
$28.3M0.0%$31.16
31
2025-Q1
Decreased
824,155
-11.8%
$27M0.0%$32.29
0
2024-Q4
New
933,952
-
$33.8M0.0%$36.91
40

Other major holders of SUPN: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used